Latest insights into the hot question of proton pump inhibitor safety – a narrative review
- 6 June 2020
- journal article
- review article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 52 (8), 842-852
- https://doi.org/10.1016/j.dld.2020.04.020
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Safety of long-term PPI therapyBest Practice & Research Clinical Gastroenterology, 2013
- The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta ProductionPLOS ONE, 2013
- Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2010
- Adverse effects of proton pump inhibitor drugs: clues and conclusionsCurrent Opinion in Gastroenterology, 2010
- Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk PatientsGastroenterology, 2010
- Marked increase in proton pump inhibitors use in AustraliaPharmacoepidemiology and Drug Safety, 2010
- Use of proton pump inhibitors and risk of osteoporosis-related fracturesCMAJ : Canadian Medical Association Journal, 2008
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of Internal Medicine, 2007
- Proton-Pump Inhibitors and Hypomagnesemic HypoparathyroidismThe New England Journal of Medicine, 2006
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004